THE Senate has obtained documents to prove that the Department of Health allowed Sanofi Pasteur to supply anti-dengue vaccines even if the pharmaceutical company has not completed its clinical trials and despite documentation “deficiencies,” Sen. Richard Gordon said on Sunday.

Gordon, chairman of the Senate Blue Ribbon Committee, said the documents, which were previously hidden from the Senate, will show the paper trail on how Sanofi was allowed to distribute Dengvaxia even if it failed to comply with the requirements needed for the vaccine’s approval. The documents, he added, will pin down former officials of the Health department and Sanofi.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details